Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.
about
Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunityLasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseasesPotential role of decoy B7-H4 in the pathogenesis of rheumatoid arthritis: a mouse model informed by clinical dataHuman T cell leukemia virus type-I and rheumatoid arthritis.Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model.Low CD4/CD8 T-cell ratio associated with inflammatory arthropathy in human T-cell leukemia virus type I Tax transgenic mice.Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease.Gamma interferon is not required for arthritis resistance in the murine Lyme disease modelCartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.Future prospects for anti-cytokine treatment.Biological agents: a novel approach to the therapy of rheumatoid arthritis.The genetic and immunopathological processes underlying collagen-induced arthritis.Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab.Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis.Role of interleukin 1 in antigen-induced exacerbations of murine arthritis.Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritisDesign of effective immunotherapy for human autoimmunity.Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids.Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition.TNFalpha blockade in human diseases: mechanisms and future directions.Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.Transmembrane tumor necrosis factor alpha is required for enteropathy and is sufficient to promote parasite expulsion in gastrointestinal helminth infectionThe vasculature in rheumatoid arthritis: cause or consequence?Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.Design, expression and characterization of a novel coexpression system of two antiarthritic molecules.Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade.Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?Combination therapy with TNFR-Fc and CTLA4-FasL using the recombinant adeno-associated virus potently suppresses adjuvant-induced arthritis in rats.Treatment of rheumatoid arthritis in the third millennium.In-vivo quantitative assessment of the therapeutic response in a mouse model of collagen-induced arthritis using 18 F-fluorodeoxyglucose positron emission tomography.Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation.Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis.Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation.Infliximab for rheumatoid arthritis.Matrine regulates Th1/Th2 cytokine responses in rheumatoid arthritis by attenuating the NF-κB signaling.Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis
P2860
Q22306446-70CCD22B-0837-4EB3-9CCB-7776DE8F3B8CQ28206018-E4C2CF22-456B-4AAC-A17A-0C390339B803Q33511443-98E1E276-32B9-4DB3-AB41-C7CF0E8D0D40Q33536189-BE9F85B9-D6DA-4384-A32C-930B227313D2Q33712966-A6BD4342-55EC-439C-B6AA-82F245A1CAD4Q33869511-FF8FF26B-D4D9-4A58-B2F7-CA2A5186379DQ33940942-23B9F627-6405-4CA1-A694-47590E0B65CCQ34007725-9602D72C-A953-4EBC-B828-31393CB36089Q34071308-74724B84-EDD8-4EB9-BD5A-63A0EB74C2EDQ34071336-9AAEFC0B-1E01-4BA4-9BE8-4F7AFC48AEDDQ34074934-62EE57E9-E350-4939-9233-FA3064F8EB76Q34351148-F37383F1-4F57-4E3D-9394-1F2AE9EDCAF4Q35041474-5D05374D-3590-4D73-B937-655893492E7AQ35547032-7D8B7348-6870-40CA-BAD9-4DA37765A6AAQ35636965-47405910-B05B-46A8-8E0F-4C973B40786DQ35788653-FD7696DD-8A62-4D91-A441-E56F3800AF1FQ35797922-95C2B657-3038-41EC-A91A-CA8F3AE9FB4CQ35834623-204EB260-E694-40FF-9B9A-FFD048A6F1C1Q36148416-ED433753-967F-4CDB-B8DB-B362832EC54CQ36365681-C82887C2-6902-4156-8EB0-B5B53A02FBDDQ36465519-C61E8C34-94FD-4153-82FE-58AF219F15EEQ36536886-E44387CD-CE86-45C3-A09A-D15BACB1CB18Q36955347-661202D5-9CB6-46FE-B9A4-E4DC4A014736Q37333359-1F7A7E91-5455-4218-966B-709FEF5841EFQ37534978-C41D0FA2-728D-48F2-8DCD-3D78106F364EQ37847059-BACDEAC7-AC7F-4A8C-A312-5C20B1DD39ECQ39184965-5DAC4411-DC22-4F81-8864-23D071769C46Q39699735-6C3B61FA-788F-461F-8D87-BBEF0C96C055Q39706642-B50F1C2D-8427-4636-B517-CC28C249829AQ42160516-66AB598D-0372-46D6-B7F5-E4C68CFCDA4FQ45153959-333D5A75-BC65-41F1-9A53-56B52F36DA47Q46433682-B76D4E9E-D10F-48E1-B2C5-0EEA5C2D324FQ46701502-6721D15A-AA12-4162-91EF-9BEA4E27ECA2Q47685842-249975A7-2033-462F-969F-DA9CAC87DB9DQ47981660-954F4815-B71D-42D1-9D4D-F833A45AEA3CQ52856626-E33D7613-AFCB-4684-9E19-721993B9ABDDQ54104639-45162CD6-60AA-4267-A3A8-DFFA7ECF1A69Q56905891-13130969-A920-4853-A935-56FD26D04771
P2860
Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Synergy between anti-CD4 and a ...... ed collagen-induced arthritis.
@ast
Synergy between anti-CD4 and a ...... ed collagen-induced arthritis.
@en
type
label
Synergy between anti-CD4 and a ...... ed collagen-induced arthritis.
@ast
Synergy between anti-CD4 and a ...... ed collagen-induced arthritis.
@en
prefLabel
Synergy between anti-CD4 and a ...... ed collagen-induced arthritis.
@ast
Synergy between anti-CD4 and a ...... ed collagen-induced arthritis.
@en
P2093
P2860
P356
P1476
Synergy between anti-CD4 and a ...... ed collagen-induced arthritis.
@en
P2093
P2860
P304
P356
10.1073/PNAS.91.7.2762
P407
P577
1994-03-01T00:00:00Z